Amdocs Stock Target Price and Analyst Consensus

DOX -  USA Stock  

USD 84.88  3.42  4.20%

The current analyst and expert consensus on Amdocs is Buy, with 0 strong sell and 2 strong buy opinions. The current projected Amdocs target price consensus is 88.2 with 5 analyst opinions. The most common way Amdocs Limited analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Amdocs executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Amdocs. We encourage you to use your own analysis of Amdocs Limited to validate this buy or sell advice. Amdocs buy-or-sell recommendation module provides average expert sentiment on the projected Amdocs Limited target price to derive its highest and lowest estimates based on projected price volatility of 7.563. Continue to Macroaxis Advice on Amdocs to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
  
Refresh
Gross Profit is likely to drop to about 1.7 B in 2022. Profit Margin is likely to drop to 0.17 in 2022. Amdocs Accounts Payable is fairly stable at the moment as compared to the past year. Amdocs reported Accounts Payable of 139.38 Million in 2021. Accumulated Other Comprehensive Income is likely to rise to about 11.6 M in 2022, whereas Receivables is likely to drop slightly above 737.4 M in 2022.

Amdocs Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Amdocs target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Amdocs target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Number of Opinions3
Lowered Outlook0
Raized Outlook0
Buy
Most Amdocs analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Amdocs stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Amdocs Limited, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Amdocs Target Price Projection

Amdocs' current and average target prices are 84.88 and 88.20, respectively. The current price of Amdocs is the price at which Amdocs Limited is currently trading. On the other hand, Amdocs' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Amdocs Market Quote on 24th of June 2022

Low Price81.97Odds
High Price85.16Odds

84.88

Target Price

Analyst Consensus On Amdocs Target Price

Low Estimate78.0Odds
High Estimate99.0Odds
Number of Analysts5
Standard Deviation7.563

88.2

Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Amdocs Limited and the information provided on this page.

Amdocs Analyst Ratings

Amdocs' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Amdocs stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Amdocs' financials, market performance, and future outlook by experienced professionals. Amdocs' historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

About Amdocs Target Price Projections

Amdocs's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Amdocs Limited and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Amdocs depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Amdocs Limited including analysis of its current option contracts.
Amdocs' latest option contracts expiring on 2022-07-15 are carrying combined implied volatility of 33.52 with a put-to-call open interest ratio of 0.22 over 30 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2022-07-15. The current put volume is at 30, with calls trading at the volume of 95. This yields a 0.32 put-to-call volume ratio. The Amdocs option chain provides detailed quote and price information for the current Amdocs Limited option contracts. It shows all of Amdocs' listed puts, calls, expiration dates, strike prices, and other pricing information.

Open Interest Against 2022-07-15 Option Contracts

Amdocs option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Amdocs' lending market. For example, when Amdocs' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Amdocs, he or she must hedge the risk by shorting Amdocs stock over its option's life.
The chart above shows Amdocs' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Amdocs' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Amdocs' option, there is no secondary market available for investors to trade.

Amdocs Maximum Pain Price across 2022-07-15 Option Contracts

Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Amdocs close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Amdocs' stock options are financial instruments that give investors the right to buy or sell shares of Amdocs Limited common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Amdocs stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Amdocs' stock price goes up or down, the stock options follow.
Continue to Macroaxis Advice on Amdocs to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.

Amdocs Limited In The Money Call Balance

When Amdocs' strike price is surpassing the current stock price, the option contract against Amdocs Limited stock is said to be in the money. When it comes to buying Amdocs' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' options written on Amdocs Limited are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Amdocs Current Options Market Mood

Amdocs' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Amdocs Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Amdocs' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Amdocs' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Amdocs' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Additional Amdocs Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Amdocs is a key component of Amdocs valuation and have some predictive power on the future returns of a Amdocs.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Amdocs' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Amdocs in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
83.1984.8786.55
Details
Intrinsic
Valuation
LowReal ValueHigh
76.3993.3495.02
Details
Naive
Forecast
LowNext ValueHigh
80.3682.0483.72
Details
Earnings
Estimates (3)
LowProjected EPSHigh
4.734.784.89
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Amdocs. Your research has to be compared to or analyzed against Amdocs' peers to derive any actionable benefits. When done correctly, Amdocs' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Amdocs Limited.

Additional Amdocs Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Amdocs is a key component of Amdocs valuation and have some predictive power on the future returns of a Amdocs.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Amdocs' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Amdocs in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
83.1984.8786.55
Details
Intrinsic
Valuation
LowReal ValueHigh
76.3993.3495.02
Details
Naive
Forecast
LowNext ValueHigh
80.3682.0483.72
Details
Earnings
Estimates (3)
LowProjected EPSHigh
4.734.784.89
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Amdocs. Your research has to be compared to or analyzed against Amdocs' peers to derive any actionable benefits. When done correctly, Amdocs' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Amdocs Limited.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index
Invested few shares
Technology
Invested over 20 shares
Continue to Macroaxis Advice on Amdocs to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. Note that the Amdocs Limited information on this page should be used as a complementary analysis to other Amdocs' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Complementary Tools for Amdocs Stock analysis

When running Amdocs Limited price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
The data published in Amdocs' official financial statements usually reflect Amdocs' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Amdocs Limited. For example, before you start analyzing numbers published by Amdocs accountants, it's critical to develop an understanding of what Amdocs' liquidity, profitability, and earnings quality are in the context of the Technology space in which it operates.
Please note, the presentation of Amdocs' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Amdocs' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Amdocs' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Amdocs Limited. Please utilize our Beneish M Score to check the likelihood of Amdocs' management to manipulate its earnings.